0

Journal Articles

in Choroidal Neovascularization
 1-20 of 56 Articles
JAMA Ophthalmology | 
Clinical Sciences |  March 01, 2013
Progression of Lesion Size in Untreated Eyes With Exudative Age-Related Macular Degeneration:  A Meta-analysis Using Lineweaver-Burk Plots
Tin Yan A. Liu, MD; Ankoor R. Shah, MD; Lucian V. Del Priore, MD, PhD
JAMA Ophthalmol. 2013;131(3):335-340. doi:10.1001/jamaophthalmol.2013.818.
JAMA Ophthalmology | 
Laboratory Sciences |  March 01, 2013
Attenuation of Choroidal Neovascularization by β2-Adrenoreceptor Antagonism
Jeremy A. Lavine, MD, PhD; Yanzhi Sang, MD, PhD; Shoujian Wang, MD, PhD; et al.
JAMA Ophthalmol. 2013;131(3):376-382. doi:10.1001/jamaophthalmol.2013.1476.
JAMA Ophthalmology | 
Research Letters |  February 01, 2013
Dramatic Resolution of Choroidal Neovascular Abnormalities After Single Aflibercept Injection Following Years of Ranibizumab Use
Voraporn Chaikitmongkol, MD; Neil M. Bressler, MD
JAMA Ophthalmol. 2013;131(2):260-262. doi:10.1001/jamaophthalmol.2013.1733.
JAMA Ophthalmology | 
Research Letters |  September 01, 2012
Reduction of Vascular Endothelial Growth Factor A in Human Breast Milk After Intravitreal Injection of Bevacizumab but Not Ranibizumab
Christoph Ehlken, MD; Gottfried Martin, MD; Andreas Stahl, MD; et al.
Arch Ophthalmol. 2012;130(9):1226-1227. doi:10.1001/archophthalmol.2012.112.
JAMA Ophthalmology | 
Research Letters |  August 01, 2012
Intravitreal Bevacizumab for Peripapillary Choroidal Neovascular Membranes
Andrew S. Davis, MD; James C. Folk, MD; Stephen R. Russell, MD; et al.
Arch Ophthalmol. 2012;130(8):1073-1075. doi:10.1001/archophthalmol.2012.465.
JAMA Ophthalmology | 
Research Letters |  July 01, 2012
Intravitreal Bevacizumab in Advanced-Stage Neovascular Age-Related Macular Degeneration With Visual Acuity Lower Than 20/200
Maurizio Battaglia Parodi, MD; Marialucia Cascavilla, MD; Alexandros Papayannis, MD; et al.
Arch Ophthalmol. 2012;130(7):934-935. doi:10.1001/archophthalmol.2011.2617.
JAMA Ophthalmology | 
Laboratory Sciences |  July 01, 2012
Compatibility of Recombinant Tissue Plasminogen Activator and Bevacizumab Co-Applied for Neovascular Age-Related Macular Degeneration With Submacular Hemorrhage
Alexa Klettner, PhD; Svenja Puls; Felix Treumer, MD; et al.
Arch Ophthalmol. 2012;130(7):875-881. doi:10.1001/archophthalmol.2012.120.
JAMA Ophthalmology | 
Laboratory Sciences |  May 01, 2012 FREE
Lack of Thrombospondin 1 and Exacerbation of Choroidal Neovascularization
Shoujian Wang, MD, PhD; Christine M. Sorenson, PhD; Nader Sheibani, PhD
Arch Ophthalmol. 2012;130(5):615-620. doi:10.1001/archopthalmol.2011.1892.
JAMA Ophthalmology | 
Laboratory Sciences |  August 01, 2011 FREE
Prevention of Experimental Choroidal Neovascularization and Resolution of Active Lesions by VEGF Trap in Nonhuman Primates
T. Michael Nork, MD, MS; Richard R. Dubielzig, DVM; Brian J. Christian, PhD; et al.
Arch Ophthalmol. 2011;129(8):1042-1052. doi:10.1001/archophthalmol.2011.210.
JAMA Ophthalmology | 
Clinical Sciences |  June 13, 2011 FREE
Estimated Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Choroidal Neovascularization:  Non-Hispanic White Population in the United States With Age-Related Macular Degeneration
Arch Ophthalmol. 2011;129(6):709-717. doi:10.1001/archophthalmol.2011.140.
JAMA Ophthalmology | 
Laboratory Sciences |  March 14, 2011 FREE
Suppression of Choroidal Neovascularization by Intravitreal Injection of Liposomal SU5416
Miki Honda, MD; Tomohiro Asai, PhD; Takuya Umemoto, MS; et al.
Arch Ophthalmol. 2011;129(3):317-321. doi:10.1001/archophthalmol.2011.12.
JAMA Ophthalmology | 
Clinical Trials |  September 01, 2010
Bevacizumab vs Photodynamic Therapy for Choroidal Neovascularization in Multifocal Choroiditis
Maurizio Battaglia Parodi, MD; Pierluigi Iacono, MD; Dimitrios Stelyos Kontadakis, MD; et al.
Arch Ophthalmol. 2010;128(9):1100-1103. doi:10.1001/archophthalmol.2010.205.
JAMA Ophthalmology | 
Laboratory Sciences |  May 01, 2010 FREE
Inhibition of Choroidal Neovascularization by Intravitreal Ketorolac
Stephen J. Kim, MD; Hassanain S. Toma, MD
Arch Ophthalmol. 2010;128(5):596-600. doi:10.1001/archophthalmol.2010.69.
JAMA Ophthalmology | 
Laboratory Sciences |  October 12, 2009 FREE
Preclinical Evaluation of the Novel Small-Molecule Integrin α5β1 Inhibitor JSM6427 in Monkey and Rabbit Models of Choroidal Neovascularization
Grit Zahn, PhD; Dörte Vossmeyer, PhD; Roland Stragies, PhD; et al.
Arch Ophthalmol. 2009;127(10):1329-1335. doi:10.1001/archophthalmol.2009.265.
JAMA Ophthalmology | 
Laboratory Sciences |  April 13, 2009 FREE
Suppression and Regression of Choroidal Neovascularization by the Multitargeted Kinase Inhibitor Pazopanib
Kyoichi Takahashi, MD, PhD; Yoshitsugu Saishin, MD, PhD; Yumiko Saishin, MD, PhD; et al.
Arch Ophthalmol. 2009;127(4):494-499. doi:10.1001/archophthalmol.2009.27.
JAMA Ophthalmology | 
Clinical Sciences |  March 09, 2009 FREE
Early Effects of Intravitreal Triamcinolone Acetonide on Inflammation and Proliferation in Human Choroidal Neovascularization
Olcay Tatar, MD; Annemarie Adam, MTA; Kei Shinoda, MD, PhD; et al.
Arch Ophthalmol. 2009;127(3):275-281. doi:10.1001/archophthalmol.2008.602.
INCLUDES: CME , Supplemental Content
JAMA Ophthalmology | 
Clinical Trials |  December 08, 2008
Surgical Removal vs Observation for Idiopathic or Ocular Histoplasmosis Syndrome–Associated Subfoveal Choroidal Neovascularization:  Vision Preference Value Scale Findings From the Randomized SST Group H Trial: SST Report No. 17
Arch Ophthalmol. 2008;126(12):1626-1632. doi:10.1001/archopht.126.12.1626.
INCLUDES: , Supplemental Content
JAMA Ophthalmology | 
Clinical Sciences |  July 14, 2008 FREE
Bevacizumab Treatment for Subfoveal Choroidal Neovascularization From Causes Other Than Age-Related Macular Degeneration
Louis K. Chang, MD, PhD; Richard F. Spaide, MD; Claudia Brue, MD; et al.
Arch Ophthalmol. 2008;126(7):941-945. doi:10.1001/archopht.126.7.941.
JAMA Ophthalmology | 
Laboratory Sciences |  July 14, 2008 FREE
Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model
Mark H. Criswell, PhD; Wen-Zheng Hu, MD, PhD; Timothy J. Steffens, MS, CRA; et al.
Arch Ophthalmol. 2008;126(7):946-952. doi:10.1001/archopht.126.7.946.
JAMA Ophthalmology | 
Clinical Sciences |  June 09, 2008 FREE
Effect of Bevacizumab on Inflammation and Proliferation in Human Choroidal Neovascularization
Olcay Tatar, MD; Efdal Yoeruek, MD; Peter Szurman, MD; et al.
Arch Ophthalmol. 2008;126(6):782-790. doi:10.1001/archopht.126.6.782.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Clinical Sciences  |  Mar 2013
Progression of Lesion Size in Untreated Eyes With Exudative Age-Related Macular Degeneration:  A Meta-analysis Using Lineweaver-Burk Plots
Tin Yan A. Liu, MD; Ankoor R. Shah, MD; Lucian V. Del Priore, MD, PhD
JAMA Ophthalmology
Laboratory Sciences  |  Mar 2013
Attenuation of Choroidal Neovascularization by β2-Adrenoreceptor Antagonism
Jeremy A. Lavine, MD, PhD; Yanzhi Sang, MD, PhD; Shoujian Wang, MD, PhD; et al.
JAMA Ophthalmology
Research Letters  |  Feb 2013
Dramatic Resolution of Choroidal Neovascular Abnormalities After Single Aflibercept Injection Following Years of Ranibizumab Use
Voraporn Chaikitmongkol, MD; Neil M. Bressler, MD
JAMA Ophthalmology
Research Letters  |  Sep 2012
Reduction of Vascular Endothelial Growth Factor A in Human Breast Milk After Intravitreal Injection of Bevacizumab but Not Ranibizumab
Christoph Ehlken, MD; Gottfried Martin, MD; Andreas Stahl, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems